Filed: 5/2/2025ACC: 0001507673-25-000009
📋 What this filing means
RP MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $138.84M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$138.84M
Total AUM (reported)
7.77M
Total Shares
Allocation by class
COM$138.84M100.0%
Portfolio Concentration
Top 3$138.84M100.0%
4–10$74.000.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 7.77M
Sole
Full voting authority
7.77M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other4
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
BIOHAVEN LTD
DFNDShares2.94M
TypeSH
Market value$70.59M
50.84%
Sole
2.94M
Shared
0.00
None
0.00
CYTOKINETICS, INC
DFNDShares980.39K
TypeSH
Market value$39.40M
28.38%
Sole
980.39K
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
DFNDShares3.85M
TypeSH
Market value$28.85M
20.78%
Sole
3.85M
Shared
0.00
None
0.00
VIRACTA THERAPEUTICS INC
DFNDShares3.70K
TypeSH
Market value$74.00
<0.01%
Sole
3.70K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BIOHAVEN LTDDFND | COM | 2.94M | SH | $70.59M 50.84% | 2.94M | 0.00 | 0.00 |
CYTOKINETICS, INCDFND | COM | 980.39K | SH | $39.40M 28.38% | 980.39K | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCDFND | COM | 3.85M | SH | $28.85M 20.78% | 3.85M | 0.00 | 0.00 |
VIRACTA THERAPEUTICS INCDFND | COM | 3.70K | SH | $74.00 <0.01% | 3.70K | 0.00 | 0.00 |